2347. Predictive Models of Fever and Adverse Outcomes in Hospitalized Patients with Neutropenia
Session: Poster Abstract Session: Transplant Infections - Epidemiology
Saturday, October 7, 2017
Room: Poster Hall CD
Background: Neutropenia is a clinical condition associated with adverse outcomes such as fever, mortality, and ICU admission. Since early intervention can decrease mortality in this population, validated early warning scores (EWS) to identify at-risk patients could result in improved outcomes. Consequently, we aimed to create optimized predictive models of fever, mortality, and adverse events in hospitalized patients with neutropenia.

Methods: Using the University of Virginia (UVA) electronic health record (EHR) data, we identified all neutropenic patients ‚Č•18 years who were admitted to inpatient wards over a five-year period. Neutropenia was defined as an absolute neutrophil count <500 cells/mm3.¬†Adverse outcomes were defined as 1) development of fever 2) ICU transfer or 3) mortality during hospital stay. We then used Bayesian model averaging to build predictive models for fever and mortality utilizing readily-available clinical laboratory and vital sign data. Finally, we built a combined adversity model (fever and/or ICU transfer and/or mortality) in the same cohort. All models were valideated using a 60:40 testing/training method.

Results: We identified 1056 patients with neutropenia admitted to UVA from 2010 to 2015. Fever occurred in 427 (40.4%) patients and 95 (8.9%) patients died. The final neutropenic fever model had a c-statistic of 0.75 and included the following variables: temperature, pulse rate, white blood cell count, and platelets. The model identified patients a median of 9.6 hours before onset of fever. The final neutropenic mortality model had a c-statistic of 0.79 and included the following variables: sodium, creatinine, potassium, ALT, platelets, albumin, and magnesium. The combined adversity model had a c-statistic of 0.69 and included the following variables: pulse, temperature, respiration, platelets, white blood cells, and albumin. The model identified patients a median of 9.3 hours before onset of fever.

Conclusion: We created predictive models for fever, mortality, and adverse outcomes in neutropenic patients. These models could easily be implemented into the EHR as an EWS to facilitate early intervention and improved outcomes in the neutropenic patient population.

Elizabeth Gulleen, MD1, Mawulolo Ameko, MS1, John Ainsworth, MS1, Prabhat Rayapati, MS1, Laura Barnes, PhD1 and Christopher Moore, MD2, (1)University of Virginia, Charlottesville, VA, (2)Medicine, University of Virginia, Charlottesville, VA

Disclosures:

E. Gulleen, None

M. Ameko, None

J. Ainsworth, None

P. Rayapati, None

L. Barnes, None

C. Moore, None

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.